Objective: The prevalence of obstructive sleep apnea (OSA) in women increases significantly after menopause. However, identifying at-risk women is difficult because they tend to underreport symptoms and their complaints may differ from those traditionally associated with OSA. We investigated whether OSA risk factors are associated with the presence of a ''nontraditional'' complaint, such as nocturnal enuresis, in postmenopausal women.
O bstructive sleep apnea (OSA) is characterized by repetitive upper airway closure, resulting in disrupted sleep and nocturnal hypoxemia. Prolonged occurrence of frequent cyclic oxygen desaturation during sleep is associated with adverse medical outcomes, especially cardiovascular disease (CVD). Best prevalence estimates suggest that OSA affects 4% of men and 2% of women. 1 Although OSA seems to predominantly affect men, women's risk of developing OSA increases significantly after menopause, 2 narrowing the difference in sex prevalence. Redline et al 3 found that the ratio of men to women reporting apnea in a community cohort is 2:1, which is greater than the previously reported ratio of 10:1 in a sleep laboratory cohort. This increase in risk may be attributed to hormonal changes related to variations in estrogen and progesterone levels, 4, 5 differences in airway collapsibility, 6 changes in adiposity, or different referral rates for polysomnography between men and women. It has been hypothesized that men report classic symptoms of OSA, leading to referral for OSA evaluation, whereas women tend to underreport their symptoms or report atypical symptoms, directing clinicians to evaluate depression or insomnia instead of OSA. 7 Underreporting of symptoms in women may be attributable to a different perception of the disease process or to actual differences in disease presentation. This highlights the importance of investigating whether other ''nontraditional'' symptoms are associated with OSA in postmenopausal women.
Recognition of nontraditional symptoms in postmenopausal women may prompt earlier evaluation for OSA in this population, which may reduce the risk of acquiring comorbid conditions such as hypertension and CVD, especially stroke. 8, 9 Treatment of OSA with positive airway pressure improves blood pressure control, cardiovascular morbidity, and cardiovascular mortality. 10, 11 A recent study from the Women's Health Initiative (WHI) demonstrated that shortduration sleep and long-duration sleep increase the risk of coronary heart disease (CHD) and CVD in postmenopausal women. 12 This association may be linked to poor sleep quality, which may be attributed to frequent arousals from either respiratory compromise or urinary urgency. In this population, snoring, which is a symptom of OSA, has been associated with a modest increase in the risk for CHD, CVD, and stroke. 13 Commonly reported symptoms of OSA include snoring, snorting, choking, gasping, periods of interrupted breathing, morning headaches, diaphoresis during sleep, interrupted sleep, and excessive daytime sleepiness. 14 Nocturia-waking up at night to urinate-is a common urinary symptom of OSA. The overall prevalence of nocturia is 47.8%, and the prevalence is greater in women. 16 That an individual voids more than two times per night should be of interest to the clinician because sleep is disrupted. 17 A previous investigation suggested that women seek medical attention when they void more than three times per night. 18 The incidence of nocturia increases with age but seems to be not affected by postmenopause status. 19 Being an expected norm of aging, pathologic nocturia is frequently overlooked. Nocturnal polyuria or pathologic nocturia has also been associated with disorders, including chronic kidney disease, congestive heart failure, neurological diseases, and venous insufficiency. 20, 21 The increase in urination is mediated by atrial natriuretic peptide (ANP), which causes increased excretion of sodium and water. The release of ANP is triggered by an increase in negative intrathoracic pressure resulting from inspiratory effort against a closed glottis, thus distending the heart. 21 In recognizing women at high risk for OSA, screening for nocturia is comparable to screening for snoring. 22 Nocturia is reversible with the application of positive airway pressure. 23 Nocturnal enuresis, a possible surrogate for nocturia, is the uncontrollable loss of urine during sleep, which may be the result of bladder dysfunction or altered anatomy. Its association with OSA has been studied extensively in children. 24 We postulate that nocturnal enuresis occurs in postmenopausal women through increased urine production and bladder and urethral dysfunction from hormonal changes, causing overflow incontinence. Therefore, postmenopausal women may present with nocturnal enuresis rather than nocturia.
We sought to determine whether OSA risk factors, such as obesity, snoring, poor sleep quality, sleep fragmentation, daytime sleepiness, and hypertension, are associated with nocturnal enuresis in a large cohort of postmenopausal women.
METHODS

Study population
The WHI consists of three clinical trials and an observational study (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , with an enrolled population of 161,808 postmenopausal women. The WHI cohort consists of multiethnic women aged between 50 and 79 years at baseline. All of these women completed the same baseline questionnaires. Methods of recruitment and study design have been previously published. [25] [26] [27] The WHI cohort was used for the study because it provided a large target population of postmenopausal women. Owing to the low prevalence of nocturnal enuresis and the paucity of literature on its association with OSA, baseline questionnaires from the complete cohort were used to ensure maximal power for testing our hypothesis. Therefore, pre hoc sample size calculation was not performed.
Outcome of nocturnal enuresis
Because the WHI clinical trials and observational study focused on comprehensive health issues in postmenopausal women, women were asked about urinary incontinence using a set of questions related to daily life experiences but were not thoroughly assessed with an existing instrument. Nocturnal enuresis was defined based on answers to the following questions. First, women were asked, ''Have you ever leaked even a small amount of urine involuntarily and you couldn't control it?'' If they answered yes, they were then asked, ''How often does this urine leaking occur?'' and ''When do you usually leak urine?'' The response options provided for the former were as follows: ''not once during the past year,'' ''less than once a month,'' ''more than once a month but less than once a week,'' ''one or more times a week but less than every day,'' and ''daily.'' The response options provided for the latter were as follows: ''when I cough, laugh, sneeze, lift, stand up, or exercise,'' ''when I feel the need to urinate and can't get to a toilet fast enough,'' and ''when I am sleeping.'' If they answered ''when I am sleeping'' to the latter question regardless of frequency, this was defined as nocturnal enuresis.
OSA risk factors
Obesity, snoring, poor sleep quality, and sleep fragmentation are predictors of OSA. 28 Body mass index (BMI) was categorized into four groups (<25, 25 to<30, 30-35, and >35 kg/m 2 ) similar to the National Institutes of Health cutoffs. 29 Obesity was defined as BMI higher than 30 kg/m 2 . Snoring, sleep quality, and sleep fragmentation were KOO ET AL evaluated with the following questions in the previously validated Women's Health Initiative Insomnia Rating Scale 12, 13, [30] [31] [32] : ''Did you snore?'', ''Overall, how was your typical night's sleep during the past 4 weeks?'', and ''Did you wake up several times at night?'', respectively. For snoring, response options were categorized into four groups: ''No,'' ''Don't know,'' ''Yes, less than or equal to two times per week,'' and ''Yes, greater than or equal to three times per week.'' For sleep quality, response options were categorized into three groups: ''average,'' ''sound or restful,'' and ''restless or worse.'' For sleep fragmentation, response options were categorized into three groups: ''No,'' ''Yes, less than or equal to two times per week,'' and ''Yes, greater than or equal to three times per week.'' Diagnosis of hypertension and questions regarding presence of daytime sleepiness are included as risk factors in several validated OSA screening questionnaires, including the Epworth Sleepiness Scale, 33 Pittsburgh Sleep Quality Index, 34 Berlin Questionnaire, 35 and STOP-Bang questionnaire. 36 Hypertension was defined as a woman reporting having been told by a physician that she had high blood pressure or hypertension. Daytime sleepiness was defined by the response to the question, ''Did you fall asleep during quiet activities like reading, watching TV, or riding a car?''
Covariates
The following baseline demographic, anthropometric, behavioral, and disease variables have been either included in previous models of sleep-related outcomes 12, 13 or associated with OSA risk factors and nocturnal enuresis. Because nocturnal enuresis may be a surrogate of nocturia, confounders of OSA-nocturia relationship also were included. 15, 22, 37 Baseline demographic characteristics included race, education, annual household income, and marital status. Race was categorized into black/African American, white, Hispanic/Latina, Asian, and other. Education was categorized into four groups: less than high school, high school graduate, some college, and college graduate. Annual household income was categorized into three ranges: less than US$20,000, between US$20,000 and US$49,999, and US$50,000 or higher. Marital status was categorized into two categories: married or partnered and single/divorced/ widowed.
Physical measurements included BMI and waist-to-hip ratio. BMI was categorized into three groups: less than 25 kg/m 2 , 25 to 30 kg/m 2 , and >30 kg/m 2 . Diabetes mellitus was defined as the use of diabetic medications. CHD, congestive heart failure, atrial fibrillation, and stroke were defined as having been diagnosed as having the disease. Use of diuretics and sedatives/hypnotics was defined as having one of the corresponding medications listed in medication records. Hormone therapy (HT) was defined as the use of exogenous hormone for replacement. HT may be protective against sleep-disordered breathing. 4 The modified Charlson comorbidity index predicts the 10-year mortality risk for a woman with given comorbidities. 38 The list of comorbidities includes previous myocardial infarction or cardiac arrest, heart failure, peripheral arterial disease, CVD, asthma, emphysema, stomach or duodenal ulcer, lupus, rheumatoid arthritis, liver disease, diabetes, leukemia, lymphoma, and several cancer types. The index was defined as a modified score ranging from 1 to 3 (1, no comorbidity; 2, one comorbidity; 3, two or more comorbidities).
Behavior risk factors included smoking, alcohol consumption, and physical activity level. Smoking was categorized into three groups: never smoker, former smoker, and current smoker. Alcohol consumption was expressed as servings per week.
Physical activity was estimated from questions asking about recreational activity and expressed in estimated metabolic equivalent of task-hours per week. Parity was defined as the number of term pregnancies and categorized into six groups (0, 1, 2, 3, 4, and !5).
OSA score
Owing to unavailability of OSA diagnosis in the WHI, we created an ''OSA'' score incorporating the following OSA risk factors: BMI of 30 kg/m 2 or higher, snoring three or more times per week, restless or worse sleep quality, wake up at night three or more times per week, diagnosis of hypertension, and presence of daytime sleepiness three or more times per week. A response of ''don't know'' for snoring was coded as ''no'' snoring. A summary score (0, no risk factor; 1, one risk factor; etc) was determined based on the presence or absence of these risk factors in any order. The association of each additional risk factor as a categorical variable with nocturnal enuresis was determined using multiple variable regression analysis.
Data synthesis and statistical analysis
To account for any residual confounding between the clinical trial cohorts and the observational study cohort, we used an indicator variable for subcohorts. We created two models (one with the subcohort indicator variable and one without the subcohort indicator variable) and compared changes in effect estimates between the two models.
We performed x 2 analysis for categorical variables and analysis of variance for continuous variables to determine the significance of the association of the outcome (nocturnal enuresis) with OSA risk factors and clinical covariates, as previously described. Missing baseline data were infrequent (<1%). We used multiple variable logistic regression analyses to adjust for known confounders of OSA risk factors and OSA-nocturnal enuresis relationship.
Other types of incontinence and categorizations of BMI may confound or decrease the precision of the proposed comparison. Because nocturnal enuresis has a mechanism similar to those of stress incontinence and urge incontinence, they may be misclassified as nocturnal enuresis or vice versa. As for BMI, because it was categorized into four groups, loss of precision may be present with the use of categories instead of a continuous measure. We performed sensitivity analyses of stress incontinence and urge incontinence and of
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continuous and categorical BMI. We created two different models (one with stress incontinence and urge incontinence and one without stress incontinence and urge incontinence) to examine the effects of daytime incontinence on nocturnal enuresis. As for BMI, we created a model using both continuous and categorical BMI and a model using only categorical BMI. If the changes in effect estimates were less than 15%, residual confounding from daytime incontinence and continuous BMI was considered negligible and was not included in the model. BMI may modify effects between OSA risk factors and nocturnal enuresis. We tested for interactions between OSA risk factors and BMI and stratified the cohort according to BMI categories (<25, 25 to <30, 30-35, and >35 kg/m 2 ) where appropriate.
All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC).
RESULTS
Of the 161,808 postmenopausal women, 2,789 women (1.7%) reported that they leaked urine while sleeping, and more than 80% of these women reported the occurrence to be at least ''more than once a month'' or more frequent. Baseline characteristics are presented in Table 1 . Women who reported nocturnal enuresis were mostly obese (50.7%). The number of comorbid conditions, including stroke, atrial fibrillation, heart failure, diabetes, and CHD, was higher in women who reported nocturnal enuresis. Increasing number of comorbid conditions also correlated with higher modified Charlson comorbidity indices. Use of diuretics and sedatives/hypnotics was higher among women who reported nocturnal enuresis. Fewer women who reported nocturnal enuresis were using HT. Women who had nocturnal enuresis were more often current and former smokers and had lower physical activity level. Parity was similar across the groups, with the exception of the group that reported five or more term pregnancies and nocturnal enuresis. Those who reported nocturnal enuresis had more snoring, worse sleep quality, more sleep fragmentation, and greater daytime sleepiness compared with those who did not report nocturnal enuresis. Hypertension was also more prevalent in those who reported nocturnal enuresis.
Unadjusted and adjusted odds ratios of nocturnal enuresis
The prevalence of nocturnal enuresis was not significantly different between the clinical trial cohorts and the observational study cohort. We did not find a significant difference in effect estimates between the model with the subcohort indicator variable and the model without the subcohort indicator variable. Therefore, the subcohort indicator variable was not included in the final model.
Unadjusted and adjusted odds ratios of nocturnal enuresis (given BMI, snoring, sleep quality, sleep fragmentation, daytime sleepiness, and hypertension) are presented in Table 2 . The odds of having nocturnal enuresis increased with BMI. The odds were greater with more frequent snoring (!3 times per week) compared with no snoring. Women who did not know if they snored had higher odds of having nocturnal enuresis relative to those who did not snore. After adjustment, an association remained for those who reported more frequent snoring (!3 times per week).
Women with restless or worse sleep quality had higher odds of having nocturnal enuresis than those with sound or restful sleep quality. After adjustment, an association remained for those who had restless or worse sleep quality. Those who woke up at night three or more times per week had greater odds of having nocturnal enuresis compared with those who did not wake up. Even after adjustment, an association remained for those who woke up at night three or more times per week.
Those who had daytime sleepiness three or more times per week had higher odds of having nocturnal enuresis compared with those who had no daytime sleepiness. After adjustment, an association remained. Women with hypertension had higher odds of having nocturnal enuresis compared with those who did not have hypertension. However, this association was attenuated after adjustment but remained significant.
Misclassification and effect measure modification
Urge incontinence and stress incontinence are more commonly reported in women who have nocturnal enuresis (64.2% and 56.4%, respectively) than in those who do not have nocturnal enuresis (37.0% and 42.3%, respectively). Sensitivity analysis revealed that the change in effect estimates of nocturnal enuresis with and without urge incontinence and stress incontinence is less than 15%. Therefore, urge incontinence and stress incontinence were not included in the final model. As for BMI, because of possible loss of precision, we compared the change in effect estimates of using either continuous or categorical BMI in four groups. The change was less than 1%. Therefore, categorical BMI was used in all analyses.
BMI is known to be associated with OSA risk factors and nocturnal enuresis. These effects vary across different strata of BMI. The interactions between BMI and each of these risk factors (sleep quality, sleep fragmentation, daytime sleepiness, and hypertension) were not significant (P ¼ 0.45, P ¼ 0.67, P ¼ 1.00, and P ¼ 0.53, respectively). However, the interaction between snoring and BMI was significant (P ¼ 0.02). Nocturnal enuresis was plotted against snoring frequency stratified by BMI category (Fig. 1) . Compared with the no-snoring group, those who had the highest frequency of snoring had higher odds of having nocturnal enuresis. The odds of having nocturnal enuresis are also higher in those who are obese (BMI !30 kg/m 2 ) than in those who are not obese.
OSA score An OSA score derived from combining one to six OSA risk factors and its association with nocturnal enuresis are presented in Table 3 . Of 2,789 women who reported nocturnal enuresis, 10% had no OSA risk factors. For those who had summary scores of 1 to 6, 19% had one risk factor, 26% had two risk factors, 22% had three risk factors, 14% had four risk KOO ET AL factors, 6% had five risk factors, and 2% had six risk factors. Each additional risk factor increased the odds of having nocturnal enuresis compared with having no risk factors, and the association is linear. Approximately half of the women had two to three OSA risk factors, and the odds of having nocturnal enuresis is three to four times higher relative to having no risk factors. If one were to have all six risk factors, the odds of having nocturnal enuresis are seven times higher compared with having no risk factors.
DISCUSSION
The association between nocturnal enuresis and OSA risk factors (including obesity, frequent snoring, restless sleep quality, sleep fragmentation, daytime sleepiness, and hypertension) in postmenopausal women has not been previously studied. We found that OSA risk factors are associated with nocturnal enuresis in this population. Even though the associations were attenuated after adjusting for known confounders, the odds of having nocturnal enuresis with any of the OSA risk factors remained significantly higher compared with those who did not have nocturnal enuresis. Obesity is a prominent risk factor for nocturnal enuresis. Furthermore, women with frequent snoring (a common symptom of OSA), along with greater BMI, had higher odds of having nocturnal enuresis compared with those who did not snore or had lower BMI. According to OSA score, each additional OSA risk factor increased the odds of having nocturnal enuresis. With the given findings, nocturnal enuresis may be an initial presenting symptom of OSA in postmenopausal women. Our study may help heighten awareness of this atypical presentation. Moreover, like snoring and nocturia, it may be useful in screening for OSA in this population.
Half of the overall cohort answered ''don't know'' to the question on snoring. The increased odds of nocturnal enuresis with such classification of snoring (''don't know'') suggests the possibility that some of these women may be snoring. This age, race, education, income, marital status, waist-to-hip ratio, diabetes, hyperlipidemia, coronary heart disease, heart failure, atrial fibrillation, stroke, hormone therapy, use of diuretics, use of sedatives/hypnotics, modified Charlson comorbidity index, smoking, alcohol consumption, physical activity, and parity.
finding implies that at-risk postmenopausal women who present with nocturnal enuresis but do not know if they snore should not be disregarded in the evaluation of OSA.
Our study confirms the findings of previous adult case reports and pediatric literature that there is a relationship between nocturnal enuresis and OSA and that diagnosis and treatment of OSA in these women abolish enuresis. [39] [40] [41] However, the population we studied is composed of postmenopausal women. Nonetheless, postmenopausal women may be more at risk because of their anatomy and the effects of hormonal variation. Although only 1.7% of the cohort reported nocturnal enuresis, the frequency of nocturnal enuresis may have been underreported probably because individuals seek medical attention only when nocturnal enuresis is problematic.
Limitations
Our study is the first to investigate the association between OSA risk factors and nocturnal enuresis in a large cohort of postmenopausal women. Although we found an association between these risk factors and nocturnal enuresis, there are a few limitations to our study. First, our study used a crosssectional design. With this design, the temporal relationship between OSA risk factors and nocturnal enuresis is unknown. However, this study provides stimulating evidence that nocturnal enuresis in the postmenopausal population may be a potential risk factor for OSA.
Second, because women self-reported incontinence, misclassification bias may have been present and may have biased effect estimates toward the null. Owing to the stigmata associated with nocturnal enuresis, those who have it may be less likely to report the symptom. Those who have it infrequently may underreport. Nocturia may also be misclassified. Many of the women with nocturnal enuresis may also have nocturia. The WHI questionnaires do not inquire about nocturia. We are unable to confirm the association between OSA risk factors and nocturia and to compare nocturnal enuresis with nocturia. However, although nocturnal enuresis and nocturia are pathophysiologically associated with ANP release during apnea-associated changes in intrathoracic pressure, nocturnal enuresis is unique given that it occurs involuntary during sleep rather than while awake like nocturia and it is probably a more salient event than nocturia. Therefore, misclassification of nocturia is less probable.
Lastly, the diagnosis ''OSA'' is not available in the WHI. We modeled OSA by incorporating several established OSA risk factors such as those found in validated screening questionnaires. All of the included OSA risk factors were significantly associated with nocturnal enuresis. The gold standard for diagnosing OSA is polysomnography, but this study provides the initial framework for investigating the causal relationship between OSA and nocturnal enuresis in the target population and in outpatient clinical settings with polysomnographic findings.
CONCLUSIONS
OSA is underdiagnosed in postmenopausal women because of underreporting of symptoms. Because nocturnal enuresis may be a presenting complaint in postmenopausal women, it may be a surrogate for nocturia, a well-described symptom of OSA (as explained by an overflow mechanism). We demonstrate that OSA risk factors are associated with nocturnal enuresis in postmenopausal women. When screening for OSA, clinicians may find it useful to inquire about nocturnal enuresis as a symptom. Postmenopausal women who present with nocturnal enuresis, along with a suspicious history or suspicious examination findings, should be questioned about other OSA risk factors. 
